Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
Clinical trial NCT00525447 · COMPLETED
Trial details
- NCT number
- NCT00525447
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.